PTJ
TLSI icon

Paul Tudor Jones’s TriSalus Life Sciences TLSI Stock Holding History

Paul Tudor Jones’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-401,403
Closed -$3.99M – 2848
2022
Q3 		$3.99M Hold
401,403
– – 0.09% 272
2022
Q2 		$3.95M Hold
401,403
– – 0.1% 243
2022
Q1 		$3.93M Hold
401,403
– – 0.09% 276
2021
Q4 		$3.97M Hold
401,403
– – 0.07% 349
2021
Q3 		$3.99M Hold
401,403
– – 0.06% 356
2021
Q2 		$3.89M Hold
401,403
– – 0.07% 310
2021
Q1 		$3.88M Buy
+401,403
New +$4.07M 0.08% 254

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
DFCM
Dark Forest Capital Management San Juan, Puerto Rico $1.55B AUM 23.63% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Paul Tudor Jones's TLSI Position: Q4 2022 in Review

Paul Tudor Jones sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 401,403 shares — an estimated $3.99M sold.

Paul Tudor Jones first reported a position in TLSI in Q1 2021 and held it in 7 quarters. The position peaked at $3.99M in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • Paul Tudor Jones reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Paul Tudor Jones sold 401,403 TriSalus Life Sciences shares in Q4 2022, an estimated $3.99M.
  • Paul Tudor Jones first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 7 quarters.
  • Paul Tudor Jones's TriSalus Life Sciences position peaked at $3.99M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.